Back to search

Article

Radiogenomics-based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance

2018-06-20

Abstract excerpt

GBM is the most common and aggressive primary brain tumor. Although the TMZ-based radiochemotherapy improves overall GBM patients’ survival, it also increases the frequency of false positive post-treatment magnetic resonance imaging (MRI) assessments for tumor progression. Pseudoprogression is a treatment-related reaction with an increase in contrast-enhancing lesion size at the tumor site or resection margins whi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7623df46-3eb5-56d9-92c0-5eadf1db9ce6
DOI
10.1101/350934
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Radiogenomics-based Risk Prediction of Glioblastoma Multiforme with Clinical RelevanceDOI 10.1101/350934
Select a neighboring publication to make it the new centre.